Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.
Alcaraz A, González-López R, Morote J, de la Piedra C, Meseguer C, Esteban E, Climent M, González-Gragera B, Alvarez-Ossorio JL, Chirivella I, Mellado B, Lara PC, Vázquez F, Contreras JA, Carles J, Murias A, Calderero V, Comet-Batlle J, González-Del Alba A, León-Mateos L, Mañas A, Segarra J, Lassa A, González-Enguita C, Méndez MJ, Samper P, Unda M, Mahillo-Fernández I, Bellmunt J; TUGAMO GROUP. Alcaraz A, et al. Among authors: samper p. Br J Cancer. 2013 Jul 9;109(1):121-30. doi: 10.1038/bjc.2013.272. Epub 2013 Jun 25. Br J Cancer. 2013. PMID: 23799855 Free PMC article.
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study.
de la Piedra C, Alcaraz A, Bellmunt J, Meseguer C, Gómez-Caamano A, Ribal MJ, Vázquez F, Anido U, Samper P, Esteban E, Álvarez-Ossorio JL, Lara PC, San José LA, Contreras JA, del Alba AG, González-Gragera B, Tabernero AJ, González-Enguita C, Fernández JM, García-Escudero A, Gómez-Veiga F, Méndez MJ, Segarra J, Virizuela JA, Carles J, Lassa A, Calderero V, Constela M, Delgado D, Mañas A, Murias A, Reynes G, Rodriguez B, Rubio G, Sánchez E, Unda M, Solsona E, Martínez-Javaloyas JM, Comet-Batlle J, Quicios C, Martín-Fernández M, Mahillo-Fernández I, Morote J. de la Piedra C, et al. Among authors: samper p. Br J Cancer. 2013 Jun 25;108(12):2565-72. doi: 10.1038/bjc.2013.270. Epub 2013 May 30. Br J Cancer. 2013. PMID: 23722472 Free PMC article. Clinical Trial.
Correlation between clinical findings and magnetic resonance imaging for the assessment of local response after standard treatment in cervical cancer.
Valduvieco I, Biete A, Rios I, Llorente R, Rovirosa A, Pahisa J, Vidal L, Farrús B, Samper P. Valduvieco I, et al. Among authors: samper p. Rep Pract Oncol Radiother. 2013 Jun 18;18(4):214-9. doi: 10.1016/j.rpor.2013.04.026. eCollection 2013. Rep Pract Oncol Radiother. 2013. PMID: 24416556 Free PMC article.
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR).
Valero J, Peleteiro P, Henríquez I, Conde A, Piquer T, Lozano A, Soler CC, Muñoz J, Illescas A, Jove J, Flores MM, Baquedano J, Diezhandino P, de Celis RP, Pardo EH, Samper P, Villoslada I, Eguiguren M, Millan V. Valero J, et al. Among authors: samper p. Clin Transl Oncol. 2020 Aug;22(8):1378-1389. doi: 10.1007/s12094-019-02274-w. Epub 2020 Jan 27. Clin Transl Oncol. 2020. PMID: 31989474
Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer.
López Torrecilla J, Zapatero A, Herruzo I, Calvo FA, Cabeza MA, Palacios A, Guerrero A, Hervás A, Lara P, Ludeña Martínez B, Del Cerro Peñalver E, Nagore G, Sancho G, Mengual JL, Mira M, Mairiño A, Samper P, Pérez S, Castillo I, Martínez Cedrés JC, Ferrer E, Rodriguez S, Maldonado X, Gómez Caamaño A, Ferrer C; Grupo de Investigación GICOR-URONCOR-SEOR. López Torrecilla J, et al. Among authors: samper p. Clin Transl Oncol. 2014 May;16(5):447-54. doi: 10.1007/s12094-013-1121-2. Epub 2013 Oct 25. Clin Transl Oncol. 2014. PMID: 24682792
Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys.
Zamora V, Garin O, Pardo Y, Pont À, Gutiérrez C, Cabrera P, Gómez-Veiga F, Pijoan JI, Litwin MS, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Zamora V, et al. Value Health. 2021 Nov;24(11):1676-1685. doi: 10.1016/j.jval.2021.03.021. Epub 2021 Sep 8. Value Health. 2021. PMID: 34711369 Free article.
The white book of radiation oncology in Spain.
Herruzo I, Romero J, Palacios A, Mañas A, Samper P, Bayo E, Guedea F; Libro Blanco de Oncología Radioterápica. Herruzo I, et al. Among authors: samper p. Clin Transl Oncol. 2011 Jun;13(6):385-95. doi: 10.1007/s12094-011-0672-3. Clin Transl Oncol. 2011. PMID: 21680299
31 results